| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 31 | 2025 | 216 | 12.570 |
Why?
|
| Coronary Artery Disease | 19 | 2025 | 316 | 9.390 |
Why?
|
| Shock, Cardiogenic | 6 | 2025 | 103 | 4.790 |
Why?
|
| Drug-Eluting Stents | 7 | 2023 | 66 | 4.440 |
Why?
|
| ST Elevation Myocardial Infarction | 10 | 2025 | 90 | 4.310 |
Why?
|
| Myocardial Infarction | 10 | 2025 | 919 | 3.540 |
Why?
|
| Cardiac Catheterization | 10 | 2020 | 286 | 3.430 |
Why?
|
| Coronary Angiography | 15 | 2025 | 206 | 3.110 |
Why?
|
| Coronary Artery Bypass | 12 | 2025 | 299 | 2.320 |
Why?
|
| Registries | 11 | 2025 | 893 | 2.070 |
Why?
|
| Coronary Stenosis | 4 | 2025 | 39 | 1.980 |
Why?
|
| Fractional Flow Reserve, Myocardial | 4 | 2018 | 19 | 1.880 |
Why?
|
| Treatment Outcome | 29 | 2025 | 5699 | 1.870 |
Why?
|
| Hospital Mortality | 6 | 2025 | 878 | 1.830 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2021 | 22 | 1.670 |
Why?
|
| Coronary Vessels | 4 | 2019 | 120 | 1.540 |
Why?
|
| Stents | 7 | 2025 | 502 | 1.520 |
Why?
|
| Aortic Valve Stenosis | 3 | 2022 | 189 | 1.500 |
Why?
|
| Retrospective Studies | 23 | 2025 | 6670 | 1.440 |
Why?
|
| Time-to-Treatment | 3 | 2025 | 112 | 1.400 |
Why?
|
| Heart Failure | 4 | 2022 | 914 | 1.180 |
Why?
|
| Catheterization, Peripheral | 2 | 2019 | 53 | 1.180 |
Why?
|
| Humans | 57 | 2025 | 63512 | 1.140 |
Why?
|
| Hemodynamics | 3 | 2025 | 250 | 1.080 |
Why?
|
| Mortality | 2 | 2019 | 160 | 1.010 |
Why?
|
| Male | 34 | 2025 | 29927 | 0.990 |
Why?
|
| Vascular Diseases | 3 | 2021 | 81 | 0.930 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2021 | 176 | 0.920 |
Why?
|
| Coronary Circulation | 1 | 2025 | 52 | 0.900 |
Why?
|
| Acute Coronary Syndrome | 2 | 2023 | 253 | 0.890 |
Why?
|
| Radial Artery | 4 | 2020 | 54 | 0.880 |
Why?
|
| Heart-Assist Devices | 2 | 2024 | 144 | 0.880 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2025 | 49 | 0.880 |
Why?
|
| Models, Cardiovascular | 1 | 2025 | 79 | 0.870 |
Why?
|
| Coronary Thrombosis | 3 | 2018 | 21 | 0.860 |
Why?
|
| Risk Factors | 15 | 2025 | 5359 | 0.840 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 109 | 0.810 |
Why?
|
| Middle Aged | 23 | 2025 | 17641 | 0.790 |
Why?
|
| Radiologists | 3 | 2019 | 91 | 0.780 |
Why?
|
| Female | 28 | 2025 | 32912 | 0.760 |
Why?
|
| Respiration, Artificial | 1 | 2025 | 297 | 0.760 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2023 | 228 | 0.730 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 141 | 0.730 |
Why?
|
| Anemia | 1 | 2023 | 127 | 0.720 |
Why?
|
| Aged | 17 | 2025 | 14469 | 0.710 |
Why?
|
| Cardiology | 2 | 2020 | 168 | 0.710 |
Why?
|
| Cardiologists | 2 | 2019 | 28 | 0.700 |
Why?
|
| Atherosclerosis | 1 | 2022 | 154 | 0.690 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 165 | 0.660 |
Why?
|
| Hirudins | 2 | 2019 | 12 | 0.660 |
Why?
|
| Middle East | 3 | 2025 | 11 | 0.650 |
Why?
|
| Ankle Brachial Index | 1 | 2019 | 13 | 0.650 |
Why?
|
| Myocardial Revascularization | 2 | 2022 | 76 | 0.630 |
Why?
|
| Saphenous Vein | 1 | 2020 | 52 | 0.630 |
Why?
|
| Ticlopidine | 2 | 2011 | 49 | 0.630 |
Why?
|
| Aneurysm | 1 | 2020 | 60 | 0.620 |
Why?
|
| Heparin | 2 | 2019 | 116 | 0.610 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2020 | 56 | 0.610 |
Why?
|
| Chest Pain | 1 | 2019 | 84 | 0.600 |
Why?
|
| Exercise Test | 2 | 2019 | 252 | 0.600 |
Why?
|
| Angina, Stable | 2 | 2016 | 11 | 0.590 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.570 |
Why?
|
| Peptide Fragments | 2 | 2019 | 410 | 0.570 |
Why?
|
| Cardiology Service, Hospital | 1 | 2017 | 17 | 0.560 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 540 | 0.550 |
Why?
|
| Patient Care Team | 2 | 2017 | 339 | 0.540 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 209 | 0.530 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 223 | 0.520 |
Why?
|
| Blood Pressure | 2 | 2018 | 512 | 0.500 |
Why?
|
| Tomography, Optical Coherence | 2 | 2020 | 224 | 0.490 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2015 | 16 | 0.470 |
Why?
|
| Severity of Illness Index | 7 | 2025 | 1553 | 0.460 |
Why?
|
| Thrombosis | 1 | 2017 | 199 | 0.460 |
Why?
|
| Bradycardia | 1 | 2015 | 33 | 0.460 |
Why?
|
| Cicatrix | 1 | 2015 | 61 | 0.450 |
Why?
|
| Hemorrhage | 3 | 2023 | 268 | 0.450 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2015 | 28 | 0.450 |
Why?
|
| Incidence | 5 | 2020 | 1380 | 0.440 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 108 | 0.440 |
Why?
|
| After-Hours Care | 1 | 2014 | 9 | 0.430 |
Why?
|
| Candidiasis | 1 | 2014 | 51 | 0.430 |
Why?
|
| Endocarditis | 1 | 2014 | 29 | 0.430 |
Why?
|
| Embolism | 1 | 2014 | 42 | 0.420 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 216 | 0.390 |
Why?
|
| Residence Characteristics | 1 | 2014 | 219 | 0.390 |
Why?
|
| Consensus | 3 | 2020 | 205 | 0.380 |
Why?
|
| Renal Circulation | 1 | 2012 | 14 | 0.380 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 8 | 0.380 |
Why?
|
| Ischemic Preconditioning | 1 | 2012 | 8 | 0.370 |
Why?
|
| Thrombectomy | 1 | 2014 | 238 | 0.370 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2012 | 28 | 0.370 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 53 | 0.360 |
Why?
|
| Coronary Restenosis | 1 | 2011 | 20 | 0.360 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 1094 | 0.360 |
Why?
|
| Endpoint Determination | 1 | 2011 | 25 | 0.360 |
Why?
|
| Stroke Volume | 2 | 2022 | 329 | 0.330 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 268 | 0.330 |
Why?
|
| Aspirin | 1 | 2011 | 172 | 0.330 |
Why?
|
| Massachusetts | 5 | 2019 | 2075 | 0.320 |
Why?
|
| Heart Valve Prosthesis | 1 | 2011 | 113 | 0.320 |
Why?
|
| Physicians | 1 | 2014 | 471 | 0.290 |
Why?
|
| Heptanoic Acids | 1 | 2008 | 22 | 0.280 |
Why?
|
| Pyrroles | 1 | 2008 | 52 | 0.280 |
Why?
|
| Physician's Role | 2 | 2019 | 124 | 0.270 |
Why?
|
| Electrocardiography | 3 | 2020 | 554 | 0.240 |
Why?
|
| Ultrasonography, Doppler | 1 | 2025 | 27 | 0.230 |
Why?
|
| Hydrodynamics | 1 | 2025 | 37 | 0.230 |
Why?
|
| Prospective Studies | 5 | 2020 | 3301 | 0.230 |
Why?
|
| Time Factors | 3 | 2025 | 3770 | 0.220 |
Why?
|
| Prevalence | 2 | 2020 | 1380 | 0.210 |
Why?
|
| Prognosis | 3 | 2018 | 1749 | 0.210 |
Why?
|
| Dissection | 2 | 2021 | 48 | 0.210 |
Why?
|
| Atrial Fibrillation | 1 | 2011 | 835 | 0.200 |
Why?
|
| Computational Biology | 1 | 2025 | 356 | 0.200 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 2462 | 0.200 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 937 | 0.190 |
Why?
|
| Stroke | 1 | 2011 | 1196 | 0.190 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 150 | 0.190 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 1655 | 0.190 |
Why?
|
| Dobutamine | 1 | 2021 | 10 | 0.190 |
Why?
|
| Echocardiography | 1 | 2025 | 502 | 0.180 |
Why?
|
| Job Description | 2 | 2019 | 24 | 0.180 |
Why?
|
| Risk Assessment | 4 | 2025 | 2082 | 0.180 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 455 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 1647 | 0.170 |
Why?
|
| Unemployment | 1 | 2021 | 18 | 0.170 |
Why?
|
| Kidney | 1 | 2023 | 447 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 774 | 0.170 |
Why?
|
| Oxygen | 2 | 2020 | 317 | 0.170 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2020 | 32 | 0.170 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 36 | 0.160 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 703 | 0.160 |
Why?
|
| Aortic Valve | 1 | 2021 | 190 | 0.160 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2020 | 74 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2018 | 572 | 0.160 |
Why?
|
| Antithrombins | 1 | 2019 | 15 | 0.160 |
Why?
|
| Global Health | 1 | 2020 | 183 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 165 | 0.150 |
Why?
|
| Radiology, Interventional | 1 | 2019 | 32 | 0.150 |
Why?
|
| Hemostatic Techniques | 1 | 2018 | 11 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 2019 | 96 | 0.150 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2018 | 7 | 0.150 |
Why?
|
| Hyperoxia | 1 | 2018 | 17 | 0.150 |
Why?
|
| Punctures | 1 | 2018 | 65 | 0.150 |
Why?
|
| Femoral Artery | 1 | 2019 | 112 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 170 | 0.140 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 196 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2019 | 193 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2017 | 1311 | 0.140 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2017 | 24 | 0.130 |
Why?
|
| Widowhood | 1 | 2017 | 5 | 0.130 |
Why?
|
| Logistic Models | 3 | 2017 | 1276 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 105 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 418 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 263 | 0.130 |
Why?
|
| Referral and Consultation | 2 | 2017 | 422 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 129 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2019 | 218 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2019 | 727 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 222 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 191 | 0.120 |
Why?
|
| Theophylline | 1 | 2015 | 10 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 673 | 0.120 |
Why?
|
| Treatment Refusal | 1 | 2015 | 56 | 0.110 |
Why?
|
| Adult | 5 | 2021 | 16837 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1003 | 0.110 |
Why?
|
| Polysomnography | 1 | 2015 | 58 | 0.110 |
Why?
|
| Inpatients | 1 | 2017 | 305 | 0.110 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 106 | 0.110 |
Why?
|
| Suction | 1 | 2014 | 36 | 0.110 |
Why?
|
| Drug Therapy, Combination | 2 | 2017 | 466 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2014 | 125 | 0.110 |
Why?
|
| Prosthesis Design | 1 | 2015 | 230 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2014 | 66 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2014 | 129 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 374 | 0.100 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2014 | 168 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2019 | 2574 | 0.100 |
Why?
|
| Pregnancy | 1 | 2020 | 2335 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2017 | 496 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 1147 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 712 | 0.090 |
Why?
|
| Troponin | 1 | 2012 | 39 | 0.090 |
Why?
|
| Creatinine | 1 | 2012 | 134 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 2578 | 0.090 |
Why?
|
| Sirolimus | 1 | 2011 | 93 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2011 | 145 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2011 | 101 | 0.090 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 21 | 0.080 |
Why?
|
| Hepatitis B | 1 | 2010 | 32 | 0.080 |
Why?
|
| Patients | 1 | 2011 | 113 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 378 | 0.080 |
Why?
|
| United States | 2 | 2018 | 7855 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2010 | 151 | 0.070 |
Why?
|
| Myocardium | 1 | 2010 | 279 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 29 | 0.070 |
Why?
|
| Health Behavior | 1 | 2011 | 469 | 0.070 |
Why?
|
| Obesity | 1 | 2015 | 1236 | 0.070 |
Why?
|
| Health Promotion | 1 | 2011 | 498 | 0.060 |
Why?
|
| Liver | 1 | 2010 | 855 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 762 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2017 | 768 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 837 | 0.050 |
Why?
|
| Wrist | 1 | 2020 | 39 | 0.040 |
Why?
|
| Arabs | 1 | 2019 | 8 | 0.040 |
Why?
|
| Hematoma | 1 | 2020 | 81 | 0.040 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2018 | 13 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2019 | 69 | 0.040 |
Why?
|
| Specialization | 1 | 2019 | 81 | 0.040 |
Why?
|
| Workload | 1 | 2019 | 128 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2019 | 199 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 210 | 0.030 |
Why?
|
| Saudi Arabia | 1 | 2017 | 7 | 0.030 |
Why?
|
| United Arab Emirates | 1 | 2017 | 4 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 107 | 0.030 |
Why?
|
| Leadership | 1 | 2019 | 207 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 20666 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 353 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 851 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 777 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2016 | 176 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 978 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 317 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 490 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1561 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2011 | 246 | 0.020 |
Why?
|
| Cholesterol | 1 | 2011 | 259 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2173 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 444 | 0.020 |
Why?
|
| Heart | 1 | 2010 | 283 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 867 | 0.020 |
Why?
|
| Smoking | 1 | 2011 | 866 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 5471 | 0.020 |
Why?
|
| Hypertension | 1 | 2011 | 587 | 0.010 |
Why?
|
| Exercise | 1 | 2011 | 942 | 0.010 |
Why?
|